Janssen Follows Gilead in Filing Federal Lawsuit to Stop Counterfeit Versions of Its HIV Drugs

By PacConAdmin | April 27, 2022

Johnson & Johnson (J&J) subsidiary Janssen has become the second big pharma company to go after drug distributors to stop the sale of counterfeit versions of its HIV drugs.
Source: Drug Industry Daily

Posted in Drug Industry Daily